Managers / Q2 2024 · view latest →
Michelson Medical Research Foundation, Inc.
CIK 0001965304 · 11755 WILSHIRE BLVD., SUITE 1400, LOS ANGELES, CA, 90025 · (310) 806-9700
Summary
Michelson Medical Research Foundation, Inc. reported $116M in U.S.-listed holdings across 25 positions for Q2 2024.
The portfolio is heavily concentrated: IVE alone accounts for 26.7% of reported value.
Compared with Q1 2024, the fund opened 4 new positions and exited 7.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 77.2% · $90M
- REIT · 19.1% · $22M
- Common Stock · 2.9% · $3M
- Closed-End Fund · 0.8% · $926,976
Quarter-over-Quarter Changes full breakdown →
vs Q1 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| GDXVANECK ETF TRUST | NEW | +234.3K | 234.3K | +$8M | $8M |
| MCHIISHARES TR | NEW | +80.0K | 80.0K | +$3M | $3M |
| SUISUN CMNTYS INC | NEW | +21.0K | 21.0K | +$3M | $3M |
| BURBURFORD CAP LTD | NEW | +120.0K | 120.0K | +$2M | $2M |
| ISHARES TR | SOLD OUT | −255.1K | 0 | −$20M | $0 |
| BKLNINVESCO EXCH TRADED FD TR II | SOLD OUT | −600.6K | 0 | −$13M | $0 |
| BSVVANGUARD BD INDEX FDS | SOLD OUT | −164.8K | 0 | −$13M | $0 |
| HDVISHARES TR | SOLD OUT | −73.2K | 0 | −$8M | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2024
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | IVEISHARES TR | S&P 500 VAL ETF · CORE S&P500 ETF · ISHARES BIOTECH · MICRO-CAP ETF · MSCI CHINA ETF | 26.66% | $31M | 225.7K |
| 2 | VEAVANGUARD TAX-MANAGED FDShistory → | VAN FTSE DEV MKT | 15.35% | $18M | 361.2K |
| 3 | VWOVANGUARD INTL EQUITY INDEX Fhistory → | FTSE EMR MKT ETF | 8.90% | $10M | 236.6K |
| 4 | EWWISHARES INC | MSCI MEXICO ETF · MSCI BRAZIL ETF · MSCI TAIWAN ETF · MSCI JPN ETF NEW · MSCI STH KOR ETF | 7.55% | $9M | 190.8K |
| 5 | AVBAVALONBAY CMNTYS INChistory → | COM | 7.38% | $9M | 41.5K |
| 6 | KRESPDR SER TR | S&P REGL BKG · S&P BIOTECH | 7.34% | $9M | 146.0K |
| 7 | GDXVANECK ETF TRUSThistory → | GOLD MINERS ETF | 6.84% | $8M | 234.3K |
| 8 | AREALEXANDRIA REAL ESTATE EQ INhistory → | COM | 4.30% | $5M | 37.2K |
| 9 | PLDPROLOGIS INC.history → | COM | 4.09% | $5M | 42.4K |
| 10 | VBVANGUARD INDEX FDShistory → | SMALL CP ETF | 3.55% | $4M | 18.9K |
| 11 | SUISUN CMNTYS INChistory → | COM | 2.17% | $3M | 21.0K |
| 12 | CRGYCRESCENT ENERGY COMPANYhistory → | CL A COM | 1.59% | $2M | 156.2K |
| 13 | BURBURFORD CAP LTDhistory → | ORD SHS | 1.35% | $2M | 120.0K |
| 14 | BXPBOSTON PROPERTIES INChistory → | COM | 1.15% | $1M | 21.7K |
| 15 | GXCSPDR INDEX SHS FDS | S&P CHINA ETF | 0.99% | $1M | 16.8K |
| 16 | NMLNEUBERGER BERMAN ENERGY INFR | COM | 0.80% | $926,976 | 115.9K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $99M | 21 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $100M | 20 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $115M | 20 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $104M | 20 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $120M | 25 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $119M | 28 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $142M | 28 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $116M | 25 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $165M | 28 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $152M | 28 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $148M | 27 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $141M | 20 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $128M | 21 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $154M | 31 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.